IS6732A - Bísýklísk heteróarómatísk efnasambönd - Google Patents

Bísýklísk heteróarómatísk efnasambönd

Info

Publication number
IS6732A
IS6732A IS6732A IS6732A IS6732A IS 6732 A IS6732 A IS 6732A IS 6732 A IS6732 A IS 6732A IS 6732 A IS6732 A IS 6732A IS 6732 A IS6732 A IS 6732A
Authority
IS
Iceland
Prior art keywords
heteroaromatic compounds
bicyclic heteroaromatic
bicyclic
compounds
heteroaromatic
Prior art date
Application number
IS6732A
Other languages
English (en)
Other versions
IS2531B (is
Inventor
Marius Timmers Cornelis
Frederik Johan Karstens Willem
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of IS6732A publication Critical patent/IS6732A/is
Publication of IS2531B publication Critical patent/IS2531B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS6732A 2000-09-22 2003-02-28 Bísýklísk heteróarómatísk efnasambönd IS2531B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22
PCT/EP2001/010743 WO2002024703A1 (en) 2000-09-22 2001-09-17 Bicyclic heteroaromatic compounds

Publications (2)

Publication Number Publication Date
IS6732A true IS6732A (is) 2003-02-28
IS2531B IS2531B (is) 2009-07-15

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6732A IS2531B (is) 2000-09-22 2003-02-28 Bísýklísk heteróarómatísk efnasambönd

Country Status (31)

Country Link
US (2) US7229990B2 (is)
EP (2) EP1322651B1 (is)
JP (1) JP4977940B2 (is)
KR (1) KR100860040B1 (is)
CN (1) CN1247594C (is)
AR (1) AR030784A1 (is)
AT (1) ATE384726T1 (is)
AU (2) AU2002213929B2 (is)
BR (1) BR0113987A (is)
CA (1) CA2422054C (is)
CY (1) CY1107308T1 (is)
CZ (1) CZ297136B6 (is)
DE (1) DE60132607T2 (is)
DK (1) DK1322651T3 (is)
EC (1) ECSP034523A (is)
ES (1) ES2299524T3 (is)
HR (1) HRP20030220B1 (is)
HU (1) HU229422B1 (is)
IL (2) IL154624A0 (is)
IS (1) IS2531B (is)
MX (1) MXPA03002478A (is)
NO (1) NO328683B1 (is)
NZ (1) NZ524444A (is)
PE (1) PE20020537A1 (is)
PL (1) PL207755B1 (is)
PT (1) PT1322651E (is)
RU (1) RU2271360C2 (is)
SK (1) SK287554B6 (is)
TW (1) TWI290143B (is)
WO (1) WO2002024703A1 (is)
ZA (1) ZA200301588B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1322651B1 (en) * 2000-09-22 2008-01-23 N.V. Organon Bicyclic heteroaromatic compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
JP4975739B2 (ja) * 2005-05-17 2012-07-11 シェーリング コーポレイション 脂質異常症の処置のための、ニコチン酸受容体アゴニストとしての複素環
AU2007254165A1 (en) * 2006-05-17 2007-11-29 Forschungsverbund Berlin E.V. Pyrimidine low molecular weight ligands for modulating hormone receptors
CN102015704A (zh) 2008-04-29 2011-04-13 霍夫曼-拉罗奇有限公司 Jnk的嘧啶基吡啶酮抑制剂
EP2358684B8 (en) 2008-10-20 2014-10-22 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
CN102791705B (zh) 2010-04-08 2016-08-03 美国政府(由卫生和人类服务部的部长所代表) 用于tsh受体的反向激动剂和中性拮抗剂
DK3392252T3 (da) * 2011-08-23 2024-01-08 Libertas Bio Inc Pyrimido-pyridazinonforbindelser og deres anvendelse
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2127736C1 (ru) * 1992-06-22 1999-03-20 Берингер Ингельгейм КГ Производные анеллированного дигидропиридина или их соли с физиологически переносимыми кислотами и средство, блокирующее неселективные катионные каналы
TW276256B (is) * 1993-08-26 1996-05-21 Takeda Pharm Industry Co Ltd
NZ284846A (en) * 1994-06-16 1998-12-23 Pfizer 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
AU712019B2 (en) * 1996-05-20 1999-10-28 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
EP1322651B1 (en) * 2000-09-22 2008-01-23 N.V. Organon Bicyclic heteroaromatic compounds

Also Published As

Publication number Publication date
HU229422B1 (hu) 2013-12-30
HRP20030220A2 (en) 2003-06-30
DE60132607T2 (de) 2009-01-29
NO20031314D0 (no) 2003-03-21
HRP20030220B1 (en) 2011-10-31
ATE384726T1 (de) 2008-02-15
HUP0302648A2 (hu) 2003-11-28
JP4977940B2 (ja) 2012-07-18
AU2002213929B2 (en) 2006-04-13
US7229990B2 (en) 2007-06-12
IL154624A (en) 2009-09-01
CZ2003828A3 (cs) 2003-08-13
CZ297136B6 (cs) 2006-09-13
WO2002024703A1 (en) 2002-03-28
KR100860040B1 (ko) 2008-09-25
HUP0302648A3 (en) 2004-11-29
CA2422054C (en) 2011-01-11
PT1322651E (pt) 2008-02-28
HK1054942A1 (en) 2003-12-19
US20030225113A1 (en) 2003-12-04
MXPA03002478A (es) 2004-05-05
AU1392902A (en) 2002-04-02
EP1886999A2 (en) 2008-02-13
CN1247594C (zh) 2006-03-29
EP1322651B1 (en) 2008-01-23
ECSP034523A (es) 2003-04-25
JP2004509896A (ja) 2004-04-02
PL360675A1 (en) 2004-09-20
CN1462273A (zh) 2003-12-17
NZ524444A (en) 2004-03-26
RU2271360C2 (ru) 2006-03-10
EP1886999A8 (en) 2010-08-04
CA2422054A1 (en) 2002-03-28
US7618963B2 (en) 2009-11-17
KR20030040483A (ko) 2003-05-22
PE20020537A1 (es) 2002-06-20
ZA200301588B (en) 2004-06-22
IL154624A0 (en) 2003-09-17
TWI290143B (en) 2007-11-21
CY1107308T1 (el) 2012-11-21
EP1886999A3 (en) 2008-03-12
BR0113987A (pt) 2003-08-12
DK1322651T3 (da) 2008-06-02
AR030784A1 (es) 2003-09-03
NO328683B1 (no) 2010-04-26
ES2299524T3 (es) 2008-06-01
IS2531B (is) 2009-07-15
PL207755B1 (pl) 2011-01-31
SK3312003A3 (en) 2003-08-05
SK287554B6 (sk) 2011-01-04
EP1322651A1 (en) 2003-07-02
US20070197527A1 (en) 2007-08-23
DE60132607D1 (de) 2008-03-13
NO20031314L (no) 2003-03-21

Similar Documents

Publication Publication Date Title
CY2015035I2 (el) Ενωσεις πυριμιδινης
NO20026196L (no) Kinazolinditosylatsalt-forbindelser
NO20024127L (no) Pyrimidin-forbindelser
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
AR027983A1 (es) Novedosos compuestos
IS2531B (is) Bísýklísk heteróarómatísk efnasambönd
IS6657A (is) Ný efnasambönd
ATE372338T1 (de) Deshalogenverbindungen
AR028220A1 (es) Novedosos compuestos
NO20030303L (no) Kalsilytiske forbindelser
NO20031837L (no) Kalsilytiske forbindelser
NO20023508L (no) Kalsilyttiske forbindelser
ATE360010T1 (de) Heterocyclische retioidverbindungen
SE0003477D0 (sv) Compounds
SE0004611D0 (sv) Novel Compounds
SE0002234D0 (sv) Novel compounds
SE0003979D0 (sv) Novel Compounds
SE0004824D0 (sv) Novel compounds
SE0003437D0 (sv) Novel compounds
SE0003436D0 (sv) Novel compounds
SE0003203D0 (sv) Novel compounds
SE0003641D0 (sv) Novel compounds
SE0000620D0 (sv) Novel compounds
SE0002331D0 (sv) Novel compounds
FI20050832L (fi) Uudet yhdisteet